AAAAAA
Results:
1-21
|
Results: 21
Authors:
CASONATO A
PONTARA E
ZERBINATI P
ZUCCHETTO A
GIROLAMI A
Citation: A. Casonato et al., THE EVALUATION OF FACTOR-VIII BINDING-ACTIVITY OF VON-WILLEBRAND-FACTOR BY MEANS OF AN ELISA METHOD - SIGNIFICANCE AND PRACTICAL IMPLICATIONS, AJCP. American journal of clinical pathology, 109(3), 1998, pp. 347-352
Authors:
GIROLAMI A
ZANON E
GAVASSO S
GIROLAMI B
ZERBINATI P
Citation: A. Girolami et al., FACTOR-V ANTIGEN IS DECREASED IN BOTH TYPES OF COMBINED FACTOR-V AND FACTOR-VIII CONGENITAL-DEFECTS, Clinical and applied thrombosis/hemostasis, 4(3), 1998, pp. 164-166
Authors:
ROSSI C
RANDI ML
ZERBINATI P
RINALDI V
GIROLAMI A
Citation: C. Rossi et al., ACUTE CORONARY-DISEASE IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA-VERA, Journal of internal medicine, 244(1), 1998, pp. 49-53
Authors:
CASONATO A
GAUCHER C
PONTARA E
ZUCCHETTO A
ZERBINATI P
MAZURIER C
GIROLAMI A
Citation: A. Casonato et al., TYPE-2N VON-WILLEBRAND-DISEASE DUE TO ARG91GLN SUBSTITUTION AND A CYTOSINE DELETION IN EXON-18 OF THE VON-WILLEBRAND-FACTOR GENE, British Journal of Haematology, 103(1), 1998, pp. 39-41
Authors:
RANDI ML
ROSSI C
MENAPACE L
CELLA G
ZERBINATI P
GIROLAMI A
Citation: Ml. Randi et al., THE SIGNIFICANCE OF ESSENTIAL THROMBOCYTHEMIA (ET) IN ADVANCED AGE (OVER 70), British Journal of Haematology, 102(1), 1998, pp. 188-188
Authors:
RANDI ML
MENAPACE L
ROSSI C
ZERBINATI P
SIMIONI P
GIROLAMI A
Citation: Ml. Randi et al., MYELOPROLIFERATIVE DISORDERS (MPDS) AND VENOUS THROMBOSIS - SIGNIFICANCE OF HEREDITARY OR ACQUIRED CLOTTING DEFECTS, British Journal of Haematology, 102(1), 1998, pp. 310-310
Authors:
PATRASSI GM
SARTORI MT
RANDI ML
ZERBINATI P
THEODORIDIS P
PONTAROLLO S
DANESIN C
GIROLAMI A
Citation: Gm. Patrassi et al., CONTRIBUTION OF PLATELETS TO PAI-1 CONCENTRATION IN PLASMA OF PATIENTS WITH PRIMARY AND SECONDARY THROMBOCYTOSIS, Fibrinolysis & proteolysis, 11(2), 1997, pp. 85-90
Authors:
ZERBINATI P
RANDI ML
ROSSI C
SOINI B
GIROLAMI A
Citation: P. Zerbinati et al., 2 METHODS FOR INTRAPLATELET SEROTONIN EVALUATION - THEIR USE IN THROMBOCYTOSIS, Clinical and applied thrombosis/hemostasis, 3(2), 1997, pp. 144-146
Authors:
RANDI ML
ROSSI C
ZERBINATI P
GIROLAMI A
Citation: Ml. Randi et al., IS MYOCARDIAL-INFARCTION AS FREQUENT IN ESSENTIAL THROMBOCYTHEMIA AS IN POLYCYTHEMIA-VERA, Thrombosis and haemostasis, 1997, pp. 182-182
Authors:
CASONATO A
PONTARA E
BIZZARO N
ZERBINATI P
ZUCCHETTO A
GIROLAMI A
Citation: A. Casonato et al., A NEW VON-WILLEBRAND DISEASE VARIANT (TYPE-2 SAN-DONA) CHARACTERIZED BY UNLIMITED VON-WILLEBRAND-FACTOR POLYMERIZATION AND INCOMPLETE OLIGOMER FORMATION, Thrombosis and haemostasis, 1997, pp. 2662-2662
Authors:
CASONATO A
PONTARA E
BERTOMORO A
ZUCCHETTO S
ZERBINATI P
GIROLAMI A
Citation: A. Casonato et al., ABNORMAL COLLAGEN-BINDING ACTIVITY OF 2A VON-WILLEBRAND-FACTOR - EVIDENCE THAT THE DEFECT DEPENDS ONLY ON THE LACK OF LARGE MULTIMERS, The Journal of laboratory and clinical medicine, 129(2), 1997, pp. 251-259
Authors:
PAOLINI R
DANDREA E
POLETTI A
DELMISTRO A
ZERBINATI P
GIROLAMI A
Citation: R. Paolini et al., B-NON-HODGKINS-LYMPHOMA IN A HEMOPHILIA PATIENT WITH IDIOPATHIC CD4-LYMPHOCYTOPENIA( T), Leukemia & lymphoma, 21(1-2), 1996, pp. 177-180
Authors:
CASONATO A
DANNHAUSER D
PONTARA E
BERTOMORO A
ORAZI B
SANTAROSSA L
ZERBINATI P
GIROLAMI A
Citation: A. Casonato et al., DDAVP INFUSION IN HEMOPHILIA-A CARRIERS - DIFFERENT BEHAVIOR OF PLASMA FACTOR-VIII AND VON-WILLEBRAND-FACTOR, Blood coagulation & fibrinolysis, 7(5), 1996, pp. 549-553
Authors:
RANDI ML
BARBONE E
ZERBINATI P
SOINI B
ROSSI C
GIROLAMI A
Citation: Ml. Randi et al., ESSENTIAL THROMBOCYTHEMIA FOLLOWING POLYCYTHEMIA-VERA - AN UNUSUAL SEQUENCE, Journal of medicine, 27(5-6), 1996, pp. 363-368
Authors:
DAZZI F
TISON T
VIANELLO F
RADOSSI P
ZERBINATI P
CARRARO P
POLETTI A
GIROLAMI A
Citation: F. Dazzi et al., HIGH-INCIDENCE OF ANTI-FVIII ANTIBODIES AGAINST NON-COAGULANT EPITOPES IN HEMOPHILIA-A PATIENTS - A POSSIBLE ROLE FOR THE HALF-LIFE OF TRANSFUSED FVIII, British Journal of Haematology, 93(3), 1996, pp. 688-693
Authors:
RANDI ML
ROSSI C
FABRIS F
ZERBINATI P
GIROLAMI A
Citation: Ml. Randi et al., ATOPIC-DERMATITIS AND ALLERGIC DISEASES WITH THROMBOCYTOSIS - A POSSIBLE LINK, Annals of allergy, asthma, & immunology, 75(6), 1995, pp. 530-532
Authors:
GIROLAMI A
SARTORI MT
ROSSI C
COGO A
ZERBINATI P
Citation: A. Girolami et al., HETEROZYGOUS FACTOR-VII DEFICIENCY AND SEVERE HEMOPHILIA-A IN THE SAME KINDRED, Blood coagulation & fibrinolysis, 6(7), 1995, pp. 676-679
Authors:
CASONATO A
PONTARA E
DANNHAEUSER D
BERTOMORO A
SARTORI MT
ZERBINATI P
GIROLAMI A
Citation: A. Casonato et al., REEVALUATION OF THE THERAPEUTIC EFFICACY OF DDAVP IN TYPE IIB VON WILLEBRANDS DISEASE, Blood coagulation & fibrinolysis, 5(6), 1994, pp. 959-964
Authors:
SARTORI MT
MARES M
ZERBINATI P
STOCCO D
GIROLAMI A
Citation: Mt. Sartori et al., REPORT ON A 3-YEAR FOLLOW-UP ZIDOVUDINE (AZT) TREATMENT IN A GROUP OFHIV-POSITIVE PATIENTS WITH CONGENITAL CLOTTING DISORDERS, Haematologia, 26(1), 1994, pp. 17-27
Authors:
DANNHAUSER D
CASONATO A
PIETROGRANDE F
PONTARA E
BERTOMORO A
ZERBINATI P
GIROLAMI A
Citation: D. Dannhauser et al., ACQUIRED FACTOR VIII-C INHIBITOR IN A PATIENT WITH SJOGRENS-SYNDROME - SUCCESSFUL TREATMENT WITH STEROID AND IMMUNOSUPPRESSIVE THERAPY, Acta haematologica, 91(2), 1994, pp. 73-76
Authors:
MARES M
SARTORI MT
ZERBINATI P
GIROLAMI A
Citation: M. Mares et al., THE IMPORTANCE OF SERIAL IMMUNOGLOBULIN EVALUATIONS IN HIV-SEROPOSITIVE HEMOPHILIACS, Haematologia, 25(4), 1993, pp. 271-276
Risultati:
1-21
|